Skip to main content
SpringerLink
Log in

When should ranolazine be considered for the treatment of chronic angina?

  • Practice Point
  • Published:

From Nature Clinical Practice Cardiovascular Medicine

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Chaitman BR (2006) Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions. Circulation 113: 2462–2472

    Article  Google Scholar 

  2. Belardinelli L et al. (2006) The mechanism of ranolazine action to reduce ischemia-induced diastolic dysfunction. Eur Heart J 8: A10–A13

    Article  CAS  Google Scholar 

  3. Antzelevitch C et al. (2004) Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties. Circulation 110: 904–910

    Article  CAS  Google Scholar 

  4. MacInnes A et al. (2003) The antianginal agent trimetazidine does not exert its functional benefit via inhibition of mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ Res 93: e26–e32

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Carol Lovegrove, Freelance Medical Writer.

Author information

Authors and Affiliations

  1. Professor of Medicine and Director of Cardiovascular Research at St Louis University School of Medicine, St Louis, MO, USA

    Bernard R Chaitman

Authors
  1. Bernard R Chaitman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bernard R Chaitman.

Ethics declarations

Competing interests

Dr Chaitman is a consultant and received research grants from CV Therapeutics, Inc.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chaitman, B. When should ranolazine be considered for the treatment of chronic angina?. Nat Rev Cardiol 3, 590–591 (2006). https://doi.org/10.1038/ncpcardio0686

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0686

  • Springer Nature Limited

Search

Navigation